Difference between revisions of "Deng Zhenling, et al. BMC Immunology (2015) cited as Ref 671 in DOI: 10.1038/s41392-020-0110-5 (Q9934)"

From Wikibase.slis.ua.edu
Jump to navigation Jump to search
(‎Created claim: title (P93): Adoptive T-cell therapy of prostate cancer targeting the cancer stem cell antigen EpCAM, #quickstatements; #temporary_batch_1590010982689)
(‎Created claim: Fifth Author string (P153): Zhang Yu-Qian, #quickstatements; #temporary_batch_1590155508986)
 
(2 intermediate revisions by the same user not shown)
Property / Page(s)
 +
1-
Property / Page(s): 1- / rank
 +
Normal rank
Property / Fourth Author string
 +
Zhang Shuren
Property / Fourth Author string: Zhang Shuren / rank
 +
Normal rank
Property / Fifth Author string
 +
Zhang Yu-Qian
Property / Fifth Author string: Zhang Yu-Qian / rank
 +
Normal rank

Latest revision as of 13:53, 22 May 2020

Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language Label Description Also known as
English
Deng Zhenling, et al. BMC Immunology (2015) cited as Ref 671 in DOI: 10.1038/s41392-020-0110-5
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8

    Statements

    Deng Zhenling
    0 references
    Wu Yanhong
    0 references
    Ma Wenbo
    0 references
    1
    0 references
    0 references
    2015
    0 references
    BMC Immunology
    0 references
    16
    0 references
    Adoptive T-cell therapy of prostate cancer targeting the cancer stem cell antigen EpCAM (English)
    0 references
    1-
    0 references
    Zhang Shuren
    0 references
    Zhang Yu-Qian
    0 references